Alto Neuroscience (ANRO) went public on the NYSE today. CEO Amit Etkin joins Nicole Petallides to give an overview of the company. Alto Neuroscience is a clinical-stage biopharmaceutical company that develops treatments for mental health. Tune in to find out more about the stock market today.
The Watch List
02 Feb 2024
SHARE
Morning Trade Live
29 Feb 2024
Market On Close
06 Mar 2024
The Watch List
05 Mar 2024
Market On Close
01 Mar 2024
Morning Trade Live
07 Mar 2024
Market On Close
30 Jan 2024